// App-Quantinova.ai

1478 : Effectiveness of Supportive Care Measurements to Reduce Infections During Induction for Children with Acute Myeloid Leukemia: A Report From the Children's Oncology Group

Researchers

Presenter

  • Richard Aplenc

Principal Investigators

  • Todd A. Alonzo

  • Robert B. Gerbing

  • Thomas Lehrnbecher

  • Alan S. Gamis

Medical Centers

  • Department of Paediatrics, Division of Emergency Medicine, The Hospital for Sick Children, Toronto, ON, Canada

  • Pediatric Hematology/Oncology, Johann Wolfgang Goethe University, Frankfurt, Germany

  • Department of Pathology, The Children's Hospital of Philadelphia, Philadelphia, PA

Locations

  • United States

  • Canada

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Acute myelocytic leukemia

  • Down syndrome

  • Neutropenia

Biomarkers

  • Granulocyte colony-stimulating factor

Drug/Treatment

  • Filgrastim

  • Gemtuzumab ozogamicin

  • Daunorubicin

  • Cytarabine liposomal

  • Penicillin

  • Benzylpenicillin

  • vancomycin capsule

  • Etoposide

  • Etoposide phosphate

Outcome

  • N/A


Study Design

  • randomized

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim